| Oct 1 |
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
|
| Oct 1 |
Merck to Hold Third-Quarter 2024 Sales and Earnings Conference Call Oct. 31
|
| Sep 30 |
Merck & Co. Inc. (MRK): A Strong Investment as KEYTRUDA Sales Drive Revenue Growth
|
| Sep 30 |
Merck & Co., Inc. (MRK) Projects 21% Upside with $140 Price Target as Keytruda and New Vaccines Drive Growth
|
| Sep 29 |
Is Merck Stock a Buy?
|
| Sep 27 |
Merck snaps six straight sessions of losses
|
| Sep 27 |
Merck & Co., Inc. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts
|
| Sep 26 |
Merck, Bristol-Myers fail to convince FDA AdCom on wider Opdivo, Keytruda use
|
| Sep 26 |
Is Merck & Co., Inc. (MRK) the Best Cheap Beginner Stock to Invest In?
|
| Sep 26 |
Evaxion stock jumps on expanded vaccine development pact with MSD
|
